I give an example: HER-2 positive breast cancer, comprising approximately 20% of all breast cancers, has a higher likelihood to spread to brain than other types of this cancer; however, the specific monoclonal antibody that has made such an important impact on the improved survival of these patients viz. The gene discussed is ERBB2; the disease is breast carcinoma.